Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_assertion type Assertion NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_head.
- NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_assertion description "[Mutational analysis showed 10 (40%) of 25 uterine endometrioid carcinomas; none of 12 uterine serous carcinomas and none of 56 ovarian serous and mucinous carcinomas harbored somatic ARID1A mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_provenance.
- NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_assertion evidence source_evidence_literature NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_provenance.
- NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_assertion SIO_000772 21412130 NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_provenance.
- NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_assertion wasDerivedFrom befree-2016 NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_provenance.
- NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_assertion wasGeneratedBy ECO_0000203 NP880192.RAyHApIxH_JiWO2DKzC5OR65pEf5WlMSpMVIz5u8o4kDw130_provenance.